Patent details

92200 Product Name: Linaclotide et toute forme thérapeutique équivalente de celui-ci, protégé par le brevet de base, y compris des sels pharmaceutiquement acceptables

Basic Information

Publication number:
92200
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP047060116
Legal Status:
Active
Application number:
92200
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/12/801/001-004
Marketing Authorization Type:
Marketing Authorization Date:
28/11/2012
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
22/05/2013
First Marketing Authorization date:
28/11/2012
Grant date:
21/03/2024
Activation date:
28/01/2024
Publication date:
02/06/2020
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
28/11/2027
SPC Extension Expiration:
28/11/2027
Rejection date:
Withdrawal date:

Owner

From:
22/05/2013
 
 

Name:
IRONWOOD PHARMACEUTICALS, INC.
Address:
301 BINNEY STREET, CAMBRIDGE, MA 02142, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
22/05/2013
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
CURRIE Mark, G.
Address:
United States (US)

2

Name:
NORMAN Thea
Address:
United States (US)

3

Name:
MILNE G. Todd
Address:
United States (US)

4

Name:
MAHAJAN-MIKLOS Shalina
Address:
United States (US)

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2020/08
Publication date:
13/07/2020
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2024/05
Publication date:
03/04/2024
Description:
Section D : Granted supplementary protection certificates – I2 publication

3

Bulletin Heading:
SPC3
Bulletin edition number:
2024/05
Publication date:
03/04/2024
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

Other

Note:
Suspension de la procédure de délivrance sur requête du déposant / Suspension of the grant procedure at the request of the applicant

Annual Fees

Annual Fee Due Date:
01/02/2027
Annual Fee Number:
24
Annual Fee Amount:
440 Euro
Expected Payer:
Last Annual Fee Payment Date:
16/01/2026
Last Annual Fee Paid Number:
23
Last Annual Fee Paid Amount:
430 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
21/03/2024 Certificate 1
21/03/2024 Publication 1
25/03/2024 Outgoing Correspondence 1
02/09/2022 Incoming Correspondence (Post) 1
08/09/2022 Outgoing Correspondence 1
02/06/2020 Publication 1